908 Devices Ownership

MASS Stock  USD 2.78  0.22  8.59%   
908 Devices secures a total of 34.82 Million outstanding shares. Over half of 908 Devices' outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in 908 Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more information on how to buy 908 Stock please use our How to Invest in 908 Devices guide.

908 Stock Ownership Analysis

About 65.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.74. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. 908 Devices recorded a loss per share of 1.79. The entity had not issued any dividends in recent years. 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts. 908 Devices operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 177 people. To find out more about 908 Devices contact Kevin Knopp at 857 254 1500 or learn more at https://908devices.com.
Besides selling stocks to institutional investors, 908 Devices also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different 908 Devices' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align 908 Devices' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

908 Devices Quarterly Liabilities And Stockholders Equity

178.28 Million

908 Devices Insider Trades History

About 8.0% of 908 Devices are currently held by insiders. Unlike 908 Devices' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against 908 Devices' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of 908 Devices' insider trades
 
Yuan Drop
 
Covid

908 Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as 908 Devices is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 908 Devices backward and forwards among themselves. 908 Devices' institutional investor refers to the entity that pools money to purchase 908 Devices' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Sumitomo Mitsui Trust Group Inc2024-12-31
467.4 K
Dimensional Fund Advisors, Inc.2024-09-30
397 K
Renaissance Technologies Corp2024-09-30
322.4 K
Junked Platinum Investment Management Ltd2024-09-30
257.4 K
Sands Capital Ventures, Llc2024-09-30
237.3 K
Citadel Advisors Llc2024-09-30
217.1 K
Nuveen Asset Management, Llc2024-09-30
204.4 K
Charles Schwab Investment Management Inc2024-12-31
201.8 K
Northern Trust Corp2024-09-30
186.7 K
Ark Investment Management Llc2024-12-31
2.8 M
Blackrock Inc2024-09-30
1.9 M
Note, although 908 Devices' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

908 Devices Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 908 Devices insiders, such as employees or executives, is commonly permitted as long as it does not rely on 908 Devices' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases 908 Devices insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

908 Devices Outstanding Bonds

908 Devices issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. 908 Devices uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most 908 bonds can be classified according to their maturity, which is the date when 908 Devices has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

908 Devices Corporate Filings

14th of February 2025
Other Reports
ViewVerify
F4
4th of February 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
10Q
12th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for 908 Stock Analysis

When running 908 Devices' price analysis, check to measure 908 Devices' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 908 Devices is operating at the current time. Most of 908 Devices' value examination focuses on studying past and present price action to predict the probability of 908 Devices' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 908 Devices' price. Additionally, you may evaluate how the addition of 908 Devices to your portfolios can decrease your overall portfolio volatility.